Adial Pharmaceuticals Prices $3.6 Mln Public Offering With Accompanying Warrants
18/6 05:28
(RTTNews) - Adial Pharmaceuticals, Inc. (ADIL), a clinical-stage biopharma company focused on addiction therapies, has priced a "reasonable best efforts" public offering totaling approximately $3.6 million in gross proceeds before fees and expenses....